INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Oppenheimer(OPY) Prnewswire·2025-01-29 21:14PLYMOUTH MEETING, Pa., Jan. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that Dr. Jacqueline Shea, INOVIO's President and CEO, and Dr. Michael Sumner, Chief Medical Officer, will be presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference.Oppenheimer 35th Annual Healthcare Life Sciences Conference ...